OxPLoreD

Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.

Chamba C. et al, (2026), Nat Med

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Parker H. et al, (2026), Leukemia

Media coverage and PATHFINDER2: hype, simplification, and free advertising.

Turnbull C. et al, (2026), Lancet Oncol, 27, 144 - 145

A call to standardize the definition of countries with a high-burden of sickle cell disease

Seabold A. et al, (2026), Journal of Sickle Cell Disease, 3

2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia.

Walewska R. et al, (2025), Br J Haematol, 207, 2296 - 2313

Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.

Domenico D. et al, (2025), Nat Commun, 16

Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemia.

Lutz C. et al, (2025), Sci Rep, 15

Evidence of latent-lytic replication in EBV-positive Burkitt lymphoma from whole genome and transcriptome sequencing

Legason I. et al, (2025)

Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia.

Munir T. et al, (2025), N Engl J Med, 393, 1177 - 1190

Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancer.

Zeisig BB. et al, (2025), Blood, 146, 1314 - 1330

Circulating tumour DNA to augment PET-CT in determining clinical outcome after head and neck cancer treatment.

Bola S. et al, (2025), Eur J Cancer, 227

Analysis of IDH1 and IDH2 mutations as causes of the hypermethylator phenotype in colorectal cancer.

Ward JC. et al, (2025), J Pathol, 267, 40 - 55

Outcomes and Risk Factors for Complications of Dermis-Fat Graft as Primary Orbital Implant.

Schuh A. et al, (2025), Ophthalmic Plast Reconstr Surg

Clinical Validation of Liquid Biopsy for Faster Molecular Diagnosis of EBV-Positive Burkitt Lymphoma

Chamba C. et al, (2025)

CMV serostatus is associated with improved survival and delayed toxicity onset following anti-PD-1 checkpoint blockade.

Milotay G. et al, (2025), Nat Med, 31, 2350 - 2364

Diagnosing Burkitt Lymphoma in Sub-Saharan Africa by Sequencing of Circulating Tumor DNA: A Comparative Microcosting Study.

Morrell L. et al, (2025), Value Health Reg Issues, 48

Rituximab for children with EBV-positive Burkitt lymphoma in East Africa.

Mawalla WF. et al, (2025), Blood Adv, 9, 2393 - 2401

A Systematic Approach to Prioritise Diagnostically Useful Findings for Inclusion in Electronic Health Records as Discrete Data to Improve Clinical Artificial Intelligence Tools and Genomic Research.

Guillod P. et al, (2025), Clin Oncol (R Coll Radiol), 39

Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis.

Schoenpflug LA. et al, (2025), J Pathol, 265, 184 - 197

Multimodal cell-free DNA whole-genome TAPS is sensitive and reveals specific cancer signals.

Vavoulis DV. et al, (2025), Nat Commun, 16

Search results

Showing results for